UBS AM’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.34M | Sell |
|
|||||
|
2025
Q2 | $3.81M | Buy |
|
|||||
|
2025
Q1 | $2.81M | Buy |
|
|||||
|
2024
Q4 | $2.52M | Buy |
|
|||||
|
2024
Q3 | $1.82M | Sell |
|
|||||
|
2024
Q2 | $1.68M | Buy |
|
|||||
|
2024
Q1 | $221K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $118K | Hold |
|
|||||
|
2023
Q1 | $118K | Hold |
|
|||||
|
2022
Q4 | $169K | Hold |
|
|||||
|
2022
Q3 | $172K | Sell |
|
|||||
|
2022
Q2 | $315K | Hold |
|
|||||
|
2022
Q1 | $413K | Hold |
|
|||||
|
2021
Q4 | $474K | Hold |
|
|||||
|
2021
Q3 | $529K | Hold |
|
|||||
|
2021
Q2 | $507K | Buy |
|
|||||
|
2021
Q1 | $585K | Sell |
|
|||||
|
2020
Q4 | $409K | Sell |
|
|||||
|
2020
Q3 | $444K | Hold |
|
|||||
|
2020
Q2 | $545K | Sell |
|
|||||
|
2020
Q1 | $406K | Buy |
|
|||||
|
2019
Q4 | $412K | Sell |
|
|||||
|
2019
Q3 | $309K | Buy |
|
|||||
|
2019
Q2 | $650K | Buy |
|
|||||
|
2019
Q1 | $817K | Buy |
|
|||||
|
2018
Q4 | $499K | Sell |
|
|||||
|
2018
Q3 | $1.12M | Buy |
|
|||||
|
2018
Q2 | $496K | Buy |
|